{
      "sword_depositor": 1,
      "note": "Imported from URDTI Journal (OAI id oai:ojs2.journal.urdti.uz:article/558)",
      "eprintid": 54643,
      "publication": "South Aral Region Medical Journal",
      "id_number": "oai:ojs2.journal.urdti.uz:article/558",
      "dir": "disk0/00/05/46/43",
      "keywords": "bronxolitiklar; beta-2 agonistlar; antimuskariniklar; inhalyatsion kortikosteroidlar; astma",
      "type": "article",
      "ispublished": "pub",
      "lastmod": "2026-05-26 15:47:13",
      "userid": 1,
      "date": "2026-04-29",
      "title": "O\u2018PKA KASALLIKLARIDA BRONXOLITIK VA YALLIG\u2018LANISHGA QARSHI PREPARATLARNING FARMAKODINAMIK TA\u2019SIRI",
      "full_text_status": "none",
      "date_type": "published",
      "rev_number": 1,
      "publisher": "South Aral Region Medical Journal",
      "eprint_status": "archive",
      "subjects": [
        "bronxolitiklar",
        "beta-2 agonistlar",
        "antimuskariniklar",
        "inhalyatsion kortikosteroidlar",
        "astma"
      ],
      "metadata_visibility": "show",
      "official_url": "http://journal.urdti.uz/index/article/view/558",
      "datestamp": "2026-05-26 15:47:13",
      "creators": [
        {
          "name": {
            "given": "Gulnoza",
            "lineage": null,
            "honourific": null,
            "family": "Qurbonova"
          }
        },
        {
          "name": {
            "lineage": null,
            "given": "Ozodbek",
            "family": "Eshqobilov",
            "honourific": null
          }
        }
      ],
      "status_changed": "2026-05-26 15:47:13",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/54643",
      "abstract": "surunkali obstruktiv o\u2018pka kasalligi (SOO\u2018K/COPD) va boshqa obstruktiv o\u2018pka kasalliklarida qo\u2018llaniladigan bronxolitik hamda yallig\u2018lanishga qarshi preparatlarning farmakodinamik ta\u2019siri tahlil qilindi. Tahlil shuni ko\u2018rsatadiki, astmada yallig\u2018lanish markaziy patogenetik mexanizm bo\u2018lgani uchun inhalyatsion kortikosteroidlar (IKS) bazis terapiyaning asosiy komponenti bo\u2018lib qoladi; bronxolitiklar esa simptomlarni tez kamaytiradi, ammo IKSsiz uzoq muddatli nazorat yetarli bo\u2018lmaydi. COPDda esa asosiy farmakodinamik tayanch uzoq ta\u2019sir qiluvchi bronxolitiklar - LABA va LAMA hisoblanadi; IKS faqat tez-tez zo\u2018rayishlar, eozinofillar yuqoriligi yoki astma-COPD kesishuvchi fenotipi mavjud holatlarda foyda-xavf nisbatiga qarab qo\u2018shiladi. Global dalillar mavzuning ahamiyatini kuchaytiradi: Jahon sog\u2018liqni saqlash tashkiloti ma\u2019lumotiga ko\u2018ra, astma 2019-yilda 262 million kishiga ta\u2019sir qilgan va 455 ming o\u2018limga sabab bo\u2018lgan, COPD esa 2021-yilda 3,5 million o\u2018limga sabab bo\u2018lgan."
    }